Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction
NCT ID: NCT01197742
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2772 participants
OBSERVATIONAL
2007-04-20
2009-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardioprotective Effect of SGLT2-I in Diabetic Patients With AMI (SGLT2-I AMI PROTECT Study)
NCT05261867
Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia
NCT05210972
Risk Prediction in Type II Diabetics With Ischemic Heart Disease
NCT01422057
Metabolic Profile as a Predictor of No-reflow in Diabetic Patients
NCT04835207
Impact of Glycemic State on Patients ST Elevation Myocardial Infarction With Primary Percutaneous Coronary Angioplasty
NCT03266978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* consecutive patients with acute (no older than 24 h) Non-ST-Elevation Myocardial infarction
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Stiftung Institut fuer Herzinfarktforschung
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anselm K Gitt, MD
Role: STUDY_CHAIR
Stiftung Institut für Herzinfarktforschung
Jochen Senges, MD
Role: STUDY_CHAIR
Stiftung Institut für Herzinfarktforschung
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Städ Krankenhaus münchen Schwabing
München, , Germany
Klinikum Nürnberg Süd /Cardiology
Nuremberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sweetheart
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.